Rodolfo José Ferreira Cavalcanti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rodolfo José Ferreira Cavalcanti has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Matheus Rodrigues Lopes
Universidade Federal do Vale do São Francisco, Brasil
2 shared publications - Carlos Alberto de Lima Botelho Filho
Universidade Federal do Vale do São Francisco, Brasil; Universidade Federal de Pernambuco, Brasil
1 shared publication - Damião Pergentino de Sousa
Laboratory of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences Federal University of Paraíba João Pessoa Paraíba Brazil
1 shared publication - Diogo Vilar da Fonsêca
Universidade Federal do Vale do São Francisco
1 shared publication - Erika Andressa Simões de Melo
Universidade Federal do Vale do São Francisco, Brazil
1 shared publication - Francisco A. A. F. Gadelha
Universidade Federal da Paraíba, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e286667
Umbelliferone presents orofacial antinociceptive and anti-inflammatory activity via reduction of TNF-α in mice
Pain is a normal response of the central nervous system to trauma, infections, neoplasms, neuropathies, and inflammation. It can arise from physical, emotional, or cognitive conditions, and is classified as orofacial pain when it affects the mouth and face. Umbelliferone, a coumarin from the umbelliferous plant family, is an important component of essential oils, and possesses antioxidant, curative, anti-inflammatory, and anti-tumor activity. The aim of this study was to investigate the orofacial antinociceptive and anti-inflammatory effects of umbelliferone in Swiss male mice Mus musculus, at 3 months of age. Test groups received different doses of umbelliferone (25, 50, or 75 mg/kg, i.p.). The negative control received 0.9% sodium chloride and Tween 80, with the positive control receiving morphine (5 mg/kg, i.p.) or dexamethasone (2 mg/kg, s.c.). We observed a significant reduction in acetic acid-induced abdominal writhing (p<0.001), and a decrease in paw licking in the orofacial nociception test with formalin (p < 0.01). The 50 and 75 mg/kg doses of umbelliferone presented significant reductions in the glutamate (p<0.01) and capsaicin (p<0.01) tests, suggesting activity on glutamatergic receptors and TRPV1. In the carrageenan-induced paw edema test (1%), there was a decrease in limb volume over 240 minutes (p<0.01), suggesting inhibition of the inflammatory process. There was also a reduction in leukocyte count (p<0.001) and TNF-α levels (p<0.001) when compared to the control group, being similar to the animals treated with dexamethasone (p<0.001). It was concluded that umbelliferone exhibits orofacial antinociceptive activity and anti-inflammatory activity via TNF-α. However, further preclinical studies are needed for a better characterization.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e286667
Open AccessUmbelliferone presents orofacial antinociceptive and anti-inflammatory activity via reduction of TNF-α in mice
Pain is a normal response of the central nervous system to trauma, infections, neoplasms, neuropathies, and inflammation. It can arise from physical, emotional, or cognitive conditions, and is classified as orofacial pain when it affects the mouth and face. Umbelliferone, a coumarin from the umbelliferous plant family, is an important component of essential oils, and possesses antioxidant, curative, anti-inflammatory, and anti-tumor activity. The aim of this study was to investigate the orofacial antinociceptive and anti-inflammatory effects of umbelliferone in Swiss male mice Mus musculus, at 3 months of age. Test groups received different doses of umbelliferone (25, 50, or 75 mg/kg, i.p.). The negative control received 0.9% sodium chloride and Tween 80, with the positive control receiving morphine (5 mg/kg, i.p.) or dexamethasone (2 mg/kg, s.c.). We observed a significant reduction in acetic acid-induced abdominal writhing (p<0.001), and a decrease in paw licking in the orofacial nociception test with formalin (p < 0.01). The 50 and 75 mg/kg doses of umbelliferone presented significant reductions in the glutamate (p<0.01) and capsaicin (p<0.01) tests, suggesting activity on glutamatergic receptors and TRPV1. In the carrageenan-induced paw edema test (1%), there was a decrease in limb volume over 240 minutes (p<0.01), suggesting inhibition of the inflammatory process. There was also a reduction in leukocyte count (p<0.001) and TNF-α levels (p<0.001) when compared to the control group, being similar to the animals treated with dexamethasone (p<0.001). It was concluded that umbelliferone exhibits orofacial antinociceptive activity and anti-inflammatory activity via TNF-α. However, further preclinical studies are needed for a better characterization.
- Open Access
- 1 February 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (2) , 335-343
Nuances between sedentary behavior and physical inactivity: cardiometabolic effects and cardiovascular risk
The aim of this study was to highlight the differences between the cardiometabolic effects and the cardiovascular risk of physical inactivity and sedentary behavior. A narrative bibliographic review was conducted. In the research, national and international articles were selected from the PubMed, SciELO, and LILACS databases using the descriptors "sedentary lifestyle, cardiovascular risk, physical inactivity, sedentary behavior, and cardiovascular risks." Both physical inactivity and sedentary behavior are related to metabolic and organic changes, promoting a chronic proinflammatory state, cardiac remodeling, increased body adiposity, and skeletal muscle dysfunction. It is possibly stated that both of them result in a higher risk of developing chronic diseases, resulting in higher global and cardiovascular morbidity and mortality, with nuances in their intrinsic effects. It is inferred that both physical inactivity and sedentary behavior are cardiovascular risk factors that can be modified with the correct clinical approach. It is necessary to differentiate physically inactive individuals from those with a high number of sedentary behaviors. These concepts need better clinical applicability to improve the prevention of primary and secondary cardiovascular risks.
- 1 February 2021
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 67 (2) , 335-343
Open AccessNuances between sedentary behavior and physical inactivity: cardiometabolic effects and cardiovascular risk
The aim of this study was to highlight the differences between the cardiometabolic effects and the cardiovascular risk of physical inactivity and sedentary behavior. A narrative bibliographic review was conducted. In the research, national and international articles were selected from the PubMed, SciELO, and LILACS databases using the descriptors "sedentary lifestyle, cardiovascular risk, physical inactivity, sedentary behavior, and cardiovascular risks." Both physical inactivity and sedentary behavior are related to metabolic and organic changes, promoting a chronic proinflammatory state, cardiac remodeling, increased body adiposity, and skeletal muscle dysfunction. It is possibly stated that both of them result in a higher risk of developing chronic diseases, resulting in higher global and cardiovascular morbidity and mortality, with nuances in their intrinsic effects. It is inferred that both physical inactivity and sedentary behavior are cardiovascular risk factors that can be modified with the correct clinical approach. It is necessary to differentiate physically inactive individuals from those with a high number of sedentary behaviors. These concepts need better clinical applicability to improve the prevention of primary and secondary cardiovascular risks.